Fc-binding M13 phage-enhanced electrochemical biosensors for influenza virus detection.

Biosens Bioelectron

Department of Integrative Biotechnology, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, Republic of Korea; Center for Biologics, Sungkyunkwan University, Suwon, Gyeonggi-do, 16419, Republic of Korea. Electronic address:

Published: January 2025

The importance of in vitro diagnostics (IVDs) has significantly increased, driving the demand for rapid and sensitive diagnostic platforms. Molecular probes play a pivotal role in improving the sensitivity and accuracy of IVDs because of their target-specific signal transduction capabilities. Antibodies, which are commonly used as detection probes, face several challenges, including limited stability, high production costs, and low signal output. In this study, we developed an engineered M13 bacteriophage-based detection system for influenza virus hemagglutinin (HA) using an Electrical ImmunoSorbent Assay (El-ISA). Our design featured Fc-binding motifs on pIII to enable conjugation with target-specific antibodies, along with signal-enhancing biotin modifications on pVIII. The resulting Fc-binding phage probes combined with anti-HA antibodies significantly improved the signal intensity by up to 6.0-fold. This approach enabled the detection of viral proteins in lysate samples at concentrations as low as 44.9 pfu/mL. These findings demonstrated the potential of Fc-binding phage probes as versatile platforms that synergize antibody specificity with enhanced signal transduction. This strategy not only enhances the sensitivity of antibody-based diagnostics but also expands their applicability in diverse research and diagnostic settings.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2025.117156DOI Listing

Publication Analysis

Top Keywords

influenza virus
8
signal transduction
8
fc-binding phage
8
phage probes
8
fc-binding
4
fc-binding m13
4
m13 phage-enhanced
4
phage-enhanced electrochemical
4
electrochemical biosensors
4
biosensors influenza
4

Similar Publications

Study of Children Aged Under 2 Years Admitted With RSV at Four Australian Hospitals [2021-2022].

J Paediatr Child Health

January 2025

WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Doherty Institute, Melbourne, Victoria, Australia.

Aims: Primary aim was to review severe acute respiratory infections (SARI) hospitalisations caused by respiratory syncytial virus (RSV) in children aged < 2 years in paediatric hospitals in Australia. Secondary aims included RSV subtyping, assessing RSV seasonality and contributing to the World Health Organisation's RSV surveillance programme.

Methods: We prospectively reviewed the medical records of children (< 2 years of age) with a confirmed SARI who were admitted to one of four major Australian paediatric hospitals and had a respiratory sample analysed by Polymerase Chain Reaction (PCR).

View Article and Find Full Text PDF

Neonates are susceptible to respiratory viral infections, with outbreaks reported in areas with a high population of neonates, such as postpartum care centers and neonatal wards. While specific antiviral drugs are currently available for influenza, symptomatic supportive treatment remains the primary approach for respiratory syncytial virus (RSV), making prevention particularly important. The article closely follows the "Expert recommendations for the prevention of common respiratory viral infections in neonates" and provides an in-depth interpretation of recent breakthroughs in RSV prevention.

View Article and Find Full Text PDF

Continuous Production of Influenza VLPs Using IC-BEVS and Multi-Stage Bioreactors.

Biotechnol Bioeng

January 2025

Instituto de Biologia Experimental e Tecnológica (iBET), Oeiras, Portugal.

The insect cell-baculovirus expression vector system (IC-BEVS) has been an asset to produce biologics for over 30 years. With the current trend in biotechnology shifting toward process intensification and integration, developing intensified processes such as continuous production is crucial to hold this platform as a suitable alternative to others. However, the implementation of continuous production has been hindered by the lytic nature of this expression system and the process-detrimental virus passage effect.

View Article and Find Full Text PDF

Background: With improved outcomes in human immunodeficiency virus (HIV) due to the use of anti-retroviral therapy, ensuring adequate preventative healthcare and management of HIV-related comorbidities is essential.

Aims: To evaluate adherence with recommended guidelines for comorbidity and immunisation status screening amongst people living with HIV within a hospital-based setting across two timepoints.

Methods: A single-centre retrospective case series was conducted at a hospital between 2011 and 2021.

View Article and Find Full Text PDF

Risk factors for re-hospitalization within 90 days of discharge for severe influenza in children.

BMC Infect Dis

January 2025

Institute of Pediatric Research, Children's Hospital of Hebei Province, 133 Jianhua South Street, Shijiazhuang, 050031, Hebei Province, China.

Background: Influenza virus is a contagious respiratory pathogen that can cause severe acute infections with long-term adverse outcomes. For paediatric patients at high risk of severe influenza, the readmission and the associated risk factors remain unclear.

Methods: Children discharged with a diagnosis of severe or critical influenza from October 2021 to March 2022 were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!